ArticleCellular oncology (Dordrecht, Netherlands)2019

Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.

Tetsuya Kokabu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.